637 related articles for article (PubMed ID: 35163593)
21. Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo.
Hsieh YL; Tu HJ; Pan SL; Liou JP; Yang CR
Biochim Biophys Acta Mol Cell Res; 2019 Jun; 1866(6):992-1003. PubMed ID: 30867138
[TBL] [Abstract][Full Text] [Related]
22. Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.
Fang F; Chen S; Ma J; Cui J; Li Q; Meng G; Wang L
Oncol Lett; 2018 Aug; 16(2):2579-2584. PubMed ID: 30013652
[TBL] [Abstract][Full Text] [Related]
23. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells.
Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
[TBL] [Abstract][Full Text] [Related]
25. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
26. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
28. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
Yang J; Zhang K; Song H; Wu M; Li J; Yong Z; Jiang S; Kuang X; Zhang T
Oncotarget; 2016 May; 7(22):32306-17. PubMed ID: 27058759
[TBL] [Abstract][Full Text] [Related]
29. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P
J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019
[TBL] [Abstract][Full Text] [Related]
30. The anti-tumor efficiency of pterostilbene is promoted with a combined treatment of Fas signaling or autophagy inhibitors in triple negative breast cancer cells.
Chen WC; Hsu KY; Hung CM; Lin YC; Yang NS; Ho CT; Kuo SC; Way TD
Food Funct; 2014 Aug; 5(8):1856-65. PubMed ID: 24944076
[TBL] [Abstract][Full Text] [Related]
31. COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway.
Wang H; Zhou H; Ni H; Shen X
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327583
[TBL] [Abstract][Full Text] [Related]
32. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
33. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.
Wei L; Yao Y; Zhao K; Huang Y; Zhou Y; Zhao L; Guo Q; Lu N
Mol Carcinog; 2016 Dec; 55(12):2121-2134. PubMed ID: 26741501
[TBL] [Abstract][Full Text] [Related]
34. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.
Wang H; Wang HS; Zhou BH; Li CL; Zhang F; Wang XF; Zhang G; Bu XZ; Cai SH; Du J
PLoS One; 2013; 8(2):e56664. PubMed ID: 23431386
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel PAK1/HDAC6 dual inhibitor ZMF-23 that triggers tubulin-stathmin regulated cell death in triple negative breast cancer.
Zhang J; Chen X; Chen G; Wang H; Jia L; Hao Y; Yao D
Int J Biol Macromol; 2023 Nov; 251():126348. PubMed ID: 37586623
[TBL] [Abstract][Full Text] [Related]
37. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.
Kashyap A; Umar SM; Dev J R A; Prasad CP
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041
[TBL] [Abstract][Full Text] [Related]
38. HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.
Oba T; Ono M; Matoba H; Uehara T; Hasegawa Y; Ito KI
Breast Cancer Res Treat; 2021 Feb; 186(1):37-51. PubMed ID: 33452951
[TBL] [Abstract][Full Text] [Related]
39. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
40. MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway.
Yang F; Xiong H; Duan L; Li Q; Li X; Zhou Y
Cancer Res Treat; 2019 Oct; 51(4):1420-1429. PubMed ID: 30913872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
